Table 1 Demographic and clinical characteristics of the study participants
Variable | Group I (Cases) n = 69 (%) | Group II (Controls) n = 50 (%) | P value |
|---|---|---|---|
Gender | |||
 Males | 36 (52.2) | 27 (54) | 0.855 |
 Females | 33 (47.8) | 23 (46) |  |
Age (years) [mean ± SD (range) | 2.1 ± 1.5 (0.6–5) | 2 ± 1.5 (0.5–5.8) | 0.720 |
  < 2 yr | 0.8 ± 0.3 (0.6–1.9) (n = 48) | 0.9 ± 0.4 (0.5–1.5) (n = 28) | 0.841 |
 2–6 y | 2.5 ± 1.1 (2.1–5) (n = 21) | 3.4 ± 1.2 (2–5.8) (n = 22) | 0.584 |
Etiology of chronic liver disease |  | – | – |
 Biliary atresia | 39 (56.5) |  |  |
 Neonatal hepatitis | 10 (14.5) |  |  |
 PFIC | 7 (10.1) |  |  |
 Glycogen storage disease | 5 (7.3) |  |  |
 Allagile syndrome | 4 (5.8) |  |  |
 CHF Child-Pugh classification | 4 (5.8) |  |  |
 Chlild-Pugh A | 17 (24.6) | – | – |
 Child-Pugh B | 35 (50.8) |  |  |
 Child-Pugh C | 17 (24.6) |  |  |